| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 145.28B | 161.33B | 140.45B | 128.03B | 113.09B | 116.91B |
| Gross Profit | 25.63B | 29.84B | 24.75B | 20.70B | 16.01B | 21.17B |
| EBITDA | 5.77B | 8.88B | 13.22B | 8.56B | 8.27B | 23.71B |
| Net Income | 17.00M | 3.69B | 5.82B | 3.50B | 3.58B | 14.27B |
Balance Sheet | ||||||
| Total Assets | 180.43B | 203.30B | 187.75B | 170.42B | 158.16B | 154.35B |
| Cash, Cash Equivalents and Short-Term Investments | 16.89B | 22.50B | 20.29B | 19.44B | 33.63B | 37.31B |
| Total Debt | 29.88B | 41.42B | 30.18B | 11.94B | 11.17B | 1.33B |
| Total Liabilities | 72.10B | 88.39B | 70.47B | 52.72B | 46.19B | 41.34B |
| Stockholders Equity | 107.24B | 113.33B | 116.11B | 117.04B | 111.54B | 112.69B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.37B | -2.65B | -12.66B | -14.84B | 1.23B |
| Operating Cash Flow | 0.00 | 3.37B | 5.22B | -1.84B | -3.42B | 6.87B |
| Investing Cash Flow | 0.00 | -7.29B | -15.07B | -9.41B | -6.82B | 10.66B |
| Financing Cash Flow | 0.00 | 6.55B | 10.79B | -1.56B | 5.12B | -1.55B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥343.82B | 11.82 | ― | 2.99% | 5.65% | 11.14% | |
74 Outperform | ¥86.90B | 13.21 | ― | 4.79% | 0.52% | 20.98% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥1.12T | 15.35 | 9.16% | 3.98% | 2.49% | -10.13% | |
56 Neutral | ¥78.62B | 22.14 | ― | 5.07% | 14.87% | -36.76% | |
52 Neutral | ¥14.55B | 2.99 | ― | 5.40% | 6.43% | ― |